Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.
NeuroX1 has raised $220K in total funding. The most recent round was Seed. The last funding was announced in March 2024.
NeuroX1's investors include Techstars, Capital Factory, Drive Capital, Trousdale Ventures, Next Sequence.
NeuroX1 is headquartered in Austin, United States.
Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.
NeuroX1 is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroX1 — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/neurox1. Accessed July 19, 2026.
VCBacked. (2024). NeuroX1 — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neurox1
{{cite web |title=NeuroX1 — Funding & Investors |url=https://www.vcbacked.co/company/neurox1 |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated